FDA approves oral Utebzi antibiotic for complicated urinary tract infections
MedicalXpress
|
Jun 23, 2026
The U.S. Food and Drug Administration has approved GSK's Utebzi (tebipenem pivoxil), an oral antibiotic, for the treatment of complicated urinary tract infections (cUTIs).
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗